Advertisement

Health


Bod to launch UK clinical trial into medicinal cannabis efficacy on long COVID

Bod to launch UK clinical trial into medicinal cannabis efficacy on long COVID

With an estimated 1.3 million people in the United Kingdom sufferin...

Ramsay Health Care to acquire UK mental health services provider for $1.4 billion

Ramsay Health Care to acquire UK mental health services provider for $1.4 billion

Australian healthcare giant Ramsay Health Care (ASX: RHC) has today...

ANTG becomes the first Australian company to ship medicinal cannabis to New Zealand

ANTG becomes the first Australian company to ship medicinal cannabis to New Zealand

With New Zealanders able to request access to medicinal cannabis dr...

Harrison.ai raises $129m, enters Sonic Healthcare JV for pathology AI solutions

Harrison.ai raises $129m, enters Sonic Healthcare JV for pathology AI solutions

Health care AI company Harrison.ai has undertaken one of Australia&...

Aged and healthcare compliance software startup Zipline.io raises $6m

Aged and healthcare compliance software startup Zipline.io raises $6m

Melbourne-based software as a service (SaaS) company Zipline.io has...

Advertisement
Advertisement
Advertisement
Why Cynata is hopeful its COVID treatment trial will succeed where others have failed

Why Cynata is hopeful its COVID treatment trial will succeed where others have failed

Cynata Therapeutics (ASX: CYP), founded by two clever stem cell r...

How Smiles Inclusive was turned upside down: A timeline of decay

How Smiles Inclusive was turned upside down: A timeline of decay

For retail investors there is something very reassuring about put...

AnteoTech spikes on customer Ellume's $304m US contract news

AnteoTech spikes on customer Ellume's $304m US contract news

Shares in Brisbane-based nanotechnology company AnteoTech (ASX: A...

Ellume secures $304m US Government contract to scale up COVID-19 test production

Ellume secures $304m US Government contract to scale up COVID-19 test production

Brisbane-based diagnostics company Ellume has today announced a U...

Tomas Steenackers mimics National Vet Care with new optometry venture

Tomas Steenackers mimics National Vet Care with new optometry venture

After the ASX-listed company he founded was offered a $251.5 mill...

Little Green Pharma finds French foothold as primary manufacturer for cannabis trial

Little Green Pharma finds French foothold as primary manufacturer for cannabis trial

Medicinal cannabis company Little Green Pharma (ASX: LGP) is toda...

Immutep's EAT COVID trial progresses to the next phase

Immutep's EAT COVID trial progresses to the next phase

A trial of biotechnology company Immutep's (ASX: IMM) experim...

AnteoTech's rapid-test success shines light on Brisbane as a COVID tech hub

AnteoTech's rapid-test success shines light on Brisbane as a COVID tech hub

AnteoTech's (ASX: ADO) plans to bring a rapid COVID-19 test t...

Ecofibre signs "milestone" international distribution deal for CBD products

Ecofibre signs "milestone" international distribution deal for CBD products

A new deal between Ecofibre (ASX: EOF) and Sydney-based pharmaceu...

Smiles Inclusive CEO resigns as Genesis Capital wins bid to acquire assets

Smiles Inclusive CEO resigns as Genesis Capital wins bid to acquire assets

After 10 months at the helm of embattled Gold Coast-based dental ...

Pro Medicus pens $40m contract with Utah's largest healthcare provider

Pro Medicus pens $40m contract with Utah's largest healthcare provider

Health imaging company Pro Medicus (ASX: PME) has today announced...

Noxopharm COVID-19 treatment trial advances to the final stage

Noxopharm COVID-19 treatment trial advances to the final stage

A trial of medtech Noxopharm's (ASX: NOX) COVID-19 treatment ...

Skin repair med-tech PolyNovo notches sales growth despite COVID hurdles

Skin repair med-tech PolyNovo notches sales growth despite COVID hurdles

Medical technology company PolyNovo (ASX: PNV) recorded 31 per ce...

Mesoblast shares crash as COVID treatment fails the test

Mesoblast shares crash as COVID treatment fails the test

Shares in Melbourne-based biotech Mesoblast (ASX: MSB) almost hal...

Ellume strikes gold in US as FDA approves rapid COVID-19 test

Ellume strikes gold in US as FDA approves rapid COVID-19 test

Brisbane Young Entrepreneur of the Year Dr Sean Parsons has achie...

Advertisement

Partner Content

With the ongoing supply chain crisis expected to continue throughou...
From COVID-19 restrictions changing the way people shop, to supply ...
The last two years have delivered major disruption to the technolog...
If you are not reassessing how your organisation remunerates and re...
Three new qualifications at The University of Notre Dame Australia ...
Property developer Aspen Group has begun work to breathe new life i...
Golf Journeys, an Australian golf travel company, has big plan...
It sounds too good to be true, but more and more Australians are di...
Advertisement